Want to see INKT full AI Analyst Report?
MiNK Therapeutics (INKT) Ownership - Who Owns MiNK Therapeutics?
MiNK Therapeutics (INKT) Ownership Overview
- 4.95% Insiders
- 1.60% Mutual Funds
- <0.01% Other Institutional Investors
- 1.46% ETFs
- 91.98% Public Companies and Individual Investors
The ownership structure of MiNK Therapeutics (INKT) stock is a mix of institutional, retail, and individual investors. Approximately 3.07% of the company’s stock is owned by Institutional Investors, 4.95% is owned by Insiders, and 91.98% is owned by Public Companies and Individual Investors.
The ownership structure of MiNK Therapeutics (INKT) stock is a mix of institutional, retail, and individual investors. Approximately 1.61% of the company’s stock is owned by Institutional Investors, 4.95% is owned by Insiders, and 1.46% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Jun 04, 2026 | Barbara Ryan | $19,130 | |
| Mar 10, 2026 | Barbara Ryan | $22,048 | |
| Mar 03, 2026 | Barbara Ryan | $5,422 |
Recent Hedge Fund Trading Activity
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Jennifer Buell | 74,195 | Insider | 1.45% | 781,273 |
| Vanguard | 68,452 | Institution | 1.34% | 720,800 |
| Vanguard Index Funds | 68,452 | Institution | 1.34% | 720,800 |
| Brian Corvese | 54,770 | Insider | 1.07% | 576,728 |
| Ulf Wiinberg | 51,759 | Insider | 1.01% | 545,022 |
| Peter Behner | 24,404 | Insider | 0.48% | 256,974 |
| Barbara Ryan | 23,591 | Insider | 0.46% | 248,413 |
| Robert Peter Kadlec | 19,126 | Insider | 0.37% | 201,397 |
| Fidelity Concord Street Trust | 13,058 | Institution | 0.26% | 137,501 |
| Ishares | 6,118 | Institution | 0.12% | 64,423 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 68,452 | Institution | 1.34% | 720,800 |
| Fidelity Concord Street Trust | 13,058 | Institution | 0.26% | 137,501 |
| Vanguard Valley Forge Funds | 208 | Institution | <0.01% | 2,190 |
Top ETF Holders
FAQ
Who Owns MiNK Therapeutics (INKT)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 4.95% is held by insiders, and 91.98% is held by retail investors.
What percentage of MiNK Therapeutics (INKT) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of MiNK Therapeutics (INKT) stock is held by institutional investors.
What percentage of MiNK Therapeutics (INKT) stock is held by retail investors?
According to the latest TipRanks data, approximately 91.98% of MiNK Therapeutics (INKT) stock is held by retail investors.
Who owns the most shares of MiNK Therapeutics (INKT)?
Jennifer Buell owns the most shares of MiNK Therapeutics (INKT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.